Ida Henriksson

Artiklar i tidskrifter

• Henriksson, I. , Udumyan, R. , Nilsson, E. , Önnerhag, K. , Rorsman, F. , Werner, M. , Marschall, H. , Wahlin, S. & et al. (2023). Clinical outcomes and sick leave in relation to UDCA treatment in Swedish patients with primary biliary cholangitis. Scandinavian Journal of Gastroenterology, 58 (1), 70-75.
• Efe, C. , Torgutalp, M. , Henriksson, I. , Alalkim, F. , Lytvyak, E. , Trivedi, H. , Eren, F. , Fischer, J. & et al. (2021). Extrahepatic autoimmune diseases in primary biliary cholangitis: Prevalence and significance for clinical presentation and disease outcome. Journal of Gastroenterology and Hepatology, 36 (4), 936-942.
• Marschall, H. , Henriksson, I. , Lindberg, S. , Söderdahl, F. , Thuresson, M. , Wahlin, S. & Ludvigsson, J. F. (2019). Incidence, prevalence, and outcome of primary biliary cholangitis in a nationwide Swedish population-based cohort. Scientific Reports, 9.
• Efe, C. , Tascilar, K. , Henriksson, I. , Lytvyak, E. , Alalkim, F. , Trivedi, H. , Eren, F. , Eliasson, J. & et al. (2019). Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis. American Journal of Gastroenterology, 114 (7), 1101-1108.